Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Appointed director
Inv. presentation
|
|
Altimmune, Inc. (PIP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 09/29/2023 |
4
| Hodges Philip (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 09/29/2023 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 09/29/2023 |
4
| GILL JOHN (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 09/29/2023 |
4
| SAYARE MITCHEL (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 09/29/2023 |
4
| Jorkasky Diane (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 26,100 options to buy
@ $2.5, valued at
$65.3k
|
|
| 08/15/2023 |
4
| Drutz David (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Bought 300 shares
@ $2.875, valued at
$862.5 |
|
| 08/02/2023 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 126 shares
@ $2.81, valued at
$354.1 |
|
| 08/02/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 1,825 shares
@ $2.81, valued at
$5.1k
|
|
| 08/02/2023 |
4
| Harris Matthew Scott (Chief Medical Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 691 shares
@ $2.81, valued at
$1.9k
|
|
| 08/02/2023 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 568 shares
@ $2.81, valued at
$1.6k
|
|
| 08/02/2023 |
4
| Jordt Raymond M (Chief Business Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 1,832 shares
@ $2.81, valued at
$5.1k
|
|
| 07/06/2023 |
4
| GILL JOHN (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Sold 2,714 shares
@ $15, valued at
$40.7k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Sohn Catherine A. (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 47,000 options to buy
@ $4.19, valued at
$196.9k
|
|
| 03/24/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Bought 10,000 shares
@ $4.314, valued at
$43.1k
|
|
| 03/23/2023 |
4
| Harris Matthew Scott (Chief Medical Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Bought 10,000 shares
@ $4.22, valued at
$42.2k
|
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 1,938 shares
@ $10.2085, valued at
$19.8k
Paid exercise price by delivering 7,658 shares
@ $13.78, valued at
$105.5k
Exercised 16,546 restricted stock units
@ $0 |
|
| 02/02/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 1,172 shares
@ $10.2085, valued at
$12k
|
|
| 02/01/2023 |
4
| Garg Vipin K (President and CEO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 302,900 options to buy
@ $12.88, valued at
$3.9M
Granted 107,100 restricted stock units
@ $0 |
|
| 02/01/2023 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 105,000 options to buy
@ $12.88, valued at
$1.4M
Granted 37,100 restricted stock units
@ $0 |
|
| 02/01/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 105,000 options to buy
@ $12.88, valued at
$1.4M
Granted 37,100 restricted stock units
@ $0 |
|
| 02/01/2023 |
4
| Harris Matthew Scott (Chief Medical Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 105,000 options to buy
@ $12.88, valued at
$1.4M
Granted 37,100 restricted stock units
@ $0 |
|
| 01/04/2023 |
4
| Jordt Raymond M (Chief Business Officer) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Granted 125,000 options to buy
@ $15.63, valued at
$2M
Granted 37,500 restricted stock units
@ $0 |
|
| 01/03/2023 |
4
| Eisenstadt Richard I (CFO) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Paid exercise price by delivering 3,028 shares
@ $16.45, valued at
$49.8k
Exercised 12,500 restricted stock units
@ $0 |
|
| 12/22/2022 |
4
| Pisano Wayne (Director) has filed a Form 4 on Altimmune, Inc.|
Txns:
| Sold 20,000 shares
@ $15.0134, valued at
$300.3k
Exercised 20,000 options to buy
@ $2.6, valued at
$52k
|
|
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|